Pat­tern Bio­science rais­es $28.7M Se­ries C for faster, more ef­fi­cient an­tibi­ot­ic re­sis­tance test

The team at Pat­tern Bio­science is work­ing on a test that can di­ag­nose drug-re­sis­tant bac­te­r­i­al in­fec­tions and iden­ti­fy ef­fec­tive an­tibi­otics with­in hours, far faster than the days it can take for tests based on cul­tures, the cur­rent stan­dard of care.

They’re start­ing out with hos­pi­tal­ized pa­tients with pneu­mo­nia, and thanks to a $28.7 mil­lion Se­ries C fi­nanc­ing round, Pat­tern says it can fin­ish de­vel­op­ment of the test, con­duct val­i­da­tion stud­ies and even­tu­al­ly sub­mit to the FDA for re­view.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER